171 related articles for article (PubMed ID: 9753710)
41. Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists.
McAleer JP
Front Allergy; 2023; 4():1167800. PubMed ID: 37051264
[TBL] [Abstract][Full Text] [Related]
42. Effects of
Muntean C; Sasaran MO; Crisan A; Banescu C
Front Public Health; 2022; 10():962852. PubMed ID: 36466447
[TBL] [Abstract][Full Text] [Related]
43. Polysaccharides influence human health
Gan L; Wang J; Guo Y
Front Nutr; 2022; 9():1030063. PubMed ID: 36438731
[TBL] [Abstract][Full Text] [Related]
44. Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population.
Gong S; Han X; Li M; Cai X; Liu W; Luo Y; Zhang SM; Zhou L; Ma Y; Huang X; Li Y; Zhou X; Zhu Y; Wang Q; Chen L; Ren Q; Zhang P; Ji L
Front Endocrinol (Lausanne); 2021; 12():677130. PubMed ID: 34764936
[TBL] [Abstract][Full Text] [Related]
45. Nuclear Receptors and Transcription Factors in Obesity-Related Kidney Disease.
Jones BA; Wang XX; Myakala K; Levi M
Semin Nephrol; 2021 Jul; 41(4):318-330. PubMed ID: 34715962
[TBL] [Abstract][Full Text] [Related]
46. PPARγ and TGFβ-Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys.
Kökény G; Calvier L; Hansmann G
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638771
[TBL] [Abstract][Full Text] [Related]
47. The beneficial effect of glycerophosphocholine to local fat accumulation: a comparative study with phosphatidylcholine and aminophylline.
Kim GW; Chung SH
Korean J Physiol Pharmacol; 2021 Jul; 25(4):333-339. PubMed ID: 34187950
[TBL] [Abstract][Full Text] [Related]
48. PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.
Cataldi S; Costa V; Ciccodicola A; Aprile M
Curr Diab Rep; 2021 Apr; 21(6):18. PubMed ID: 33866450
[TBL] [Abstract][Full Text] [Related]
49. INPP4B protects from metabolic syndrome and associated disorders.
Zhang M; Ceyhan Y; Kaftanovskaya EM; Vasquez JL; Vacher J; Knop FK; Nathanson L; Agoulnik AI; Ittmann MM; Agoulnik IU
Commun Biol; 2021 Mar; 4(1):416. PubMed ID: 33772116
[TBL] [Abstract][Full Text] [Related]
50. Novel Genetic Variants of
Wu L; Song Y; Zhang Y; Liang B; Deng Y; Tang T; Ye YC; Hou HY; Wang CC
Front Endocrinol (Lausanne); 2020; 11():499788. PubMed ID: 33551986
[TBL] [Abstract][Full Text] [Related]
51. Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling.
Wang L; Luo Y; Luo L; Wu D; Ding X; Zheng H; Wu H; Liu B; Yang X; Silva F; Wang C; Zhang X; Zheng X; Chen J; Brigman J; Mandell M; Zhou Z; Liu F; Yang XO; Liu M
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33104171
[TBL] [Abstract][Full Text] [Related]
52. Nuclear receptors in podocyte biology and glomerular disease.
Agrawal S; He JC; Tharaux PL
Nat Rev Nephrol; 2021 Mar; 17(3):185-204. PubMed ID: 32943753
[TBL] [Abstract][Full Text] [Related]
53. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
[TBL] [Abstract][Full Text] [Related]
54. The role and function of PPARγ in bladder cancer.
Peng T; Wang G; Cheng S; Xiong Y; Cao R; Qian K; Ju L; Wang X; Xiao Y
J Cancer; 2020; 11(13):3965-3975. PubMed ID: 32328200
[TBL] [Abstract][Full Text] [Related]
55. Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM; Zhang B; Hornbeck PV; Gnad F
BMC Med Genomics; 2019 Jul; 12(Suppl 6):109. PubMed ID: 31345222
[TBL] [Abstract][Full Text] [Related]
56. ASSOCIATION OF THE HUMAN PPARγ2 PRO12ALA POLYMORPHISM WITH OBESITY IN A POPULATION FROM TURKEY.
Sözen MA; Özcan MU; Çıldır M; Doğru IH; Aygök AG; Balkan KÜ
Acta Endocrinol (Buchar); 2018; 14(4):459-465. PubMed ID: 31149297
[TBL] [Abstract][Full Text] [Related]
57. Peroxisome Proliferator-Activated Receptor-γ Gene Polymorphism in Psoriasis and Its Relation to Obesity, Metabolic Syndrome, and Narrowband Ultraviolet B Response: A Case-Control Study in Egyptian Patients.
Seleit I; Bakry OA; Abd El Gayed E; Ghanem M
Indian J Dermatol; 2019; 64(3):192-200. PubMed ID: 31148857
[TBL] [Abstract][Full Text] [Related]
58. Recurrent activating mutations of PPARγ associated with luminal bladder tumors.
Rochel N; Krucker C; Coutos-Thévenot L; Osz J; Zhang R; Guyon E; Zita W; Vanthong S; Hernandez OA; Bourguet M; Badawy KA; Dufour F; Peluso-Iltis C; Heckler-Beji S; Dejaegere A; Kamoun A; de Reyniès A; Neuzillet Y; Rebouissou S; Béraud C; Lang H; Massfelder T; Allory Y; Cianférani S; Stote RH; Radvanyi F; Bernard-Pierrot I
Nat Commun; 2019 Jan; 10(1):253. PubMed ID: 30651555
[TBL] [Abstract][Full Text] [Related]
59. Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma.
Corrales P; Izquierdo-Lahuerta A; Medina-Gómez G
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30012954
[TBL] [Abstract][Full Text] [Related]
60. Functional Regulation of PPARs through Post-Translational Modifications.
Brunmeir R; Xu F
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
